251 related articles for article (PubMed ID: 29538636)
1. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
Arenas-Pinto A; Grund B; Sharma S; Martinez E; Cummins N; Fox J; Klingman KL; Sedlacek D; Collins S; Flynn PM; Chasanov WM; Kedem E; Katlama C; Sierra-Madero J; Afonso C; Brouwers P; Cooper DA;
Clin Infect Dis; 2018 Jul; 67(3):420-429. PubMed ID: 29538636
[TBL] [Abstract][Full Text] [Related]
2. Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
Török ME; Yen NT; Chau TT; Mai NT; Phu NH; Mai PP; Dung NT; Chau NV; Bang ND; Tien NA; Minh NH; Hien NQ; Thai PV; Dong DT; Anh DT; Thoa NT; Hai NN; Lan NN; Lan NT; Quy HT; Dung NH; Hien TT; Chinh NT; Simmons CP; de Jong M; Wolbers M; Farrar JJ
Clin Infect Dis; 2011 Jun; 52(11):1374-83. PubMed ID: 21596680
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care.
Bengtson AM; Pence BW; Mollan KR; Edwards JK; Moore RD; OʼCleirigh C; Eaton EF; Eron JJ; Kitahata MM; Mathews WC; Crane H; Mugavero MJ
J Acquir Immune Defic Syndr; 2017 Dec; 76(4):402-408. PubMed ID: 28749824
[TBL] [Abstract][Full Text] [Related]
5. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings.
van Dijk JH; Sutcliffe CG; Hamangaba F; Bositis C; Watson DC; Moss WJ
PLoS One; 2013; 8(1):e55111. PubMed ID: 23372824
[TBL] [Abstract][Full Text] [Related]
7. Hepatotoxicity and Liver-Related Mortality in Women of Childbearing Potential Living With Human Immunodeficiency Virus and High CD4 Cell Counts Initiating Efavirenz-Containing Regimens.
Bhattacharya D; Gupta A; Tierney C; Huang S; Peters MG; Chipato T; Martinson F; Mohtashemi N; Dula D; George K; Chaktoura N; Klingman KL; Gnanashanmugam D; Currier JS; Fowler MG
Clin Infect Dis; 2021 Apr; 72(8):1342-1349. PubMed ID: 32161944
[TBL] [Abstract][Full Text] [Related]
8. Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting.
Hermans SM; Manabe YC; Kiragga AN; Hoepelman AI; Lange JM; van Leth F
Antivir Ther; 2013; 18(4):615-22. PubMed ID: 23423604
[TBL] [Abstract][Full Text] [Related]
9. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.
Mollan KR; Smurzynski M; Eron JJ; Daar ES; Campbell TB; Sax PE; Gulick RM; Na L; O'Keefe L; Robertson KR; Tierney C
Ann Intern Med; 2014 Jul; 161(1):1-10. PubMed ID: 24979445
[TBL] [Abstract][Full Text] [Related]
10. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.
Brown TT; McComsey GA
Antivir Ther; 2010; 15(3):425-9. PubMed ID: 20516561
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Dolutegravir Versus Efavirenz-Based Antiviral Regimen in People Living With HIV-1 in Sichuan Province of China: A Real-World Study.
Tongtong Y; Shenghua H; Yin W; Lin C; Huanxia L; Chunrong L; Ruifeng Z; Xiaojing Y; Yuan Y; Yuanhong H; Ke Y
J Acquir Immune Defic Syndr; 2022 Oct; 91(S1):S1-S7. PubMed ID: 36094508
[TBL] [Abstract][Full Text] [Related]
12. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903.
Berenguer J; González J; Ribera E; Domingo P; Santos J; Miralles P; Angels Ribas M; Asensi V; Gimeno JL; Pérez-Molina JA; Terrón JA; Santamaría JM; Pedrol E;
Clin Infect Dis; 2008 Oct; 47(8):1083-92. PubMed ID: 18781872
[TBL] [Abstract][Full Text] [Related]
13. The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection.
Sharma S; Schlusser KE; de la Torre P; Tambussi G; Draenert R; Pinto AN; Metcalf JA; Neaton JD; Laeyendecker O;
AIDS; 2019 Jul; 33(8):1335-1344. PubMed ID: 31157663
[TBL] [Abstract][Full Text] [Related]
14. The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy.
Carr A; Grund B; Schwartz AV; Avihingsanon A; Badal-Faesen S; Bernadino JI; Estrada V; La Rosa A; Mallon P; Pujari S; White D; Wyman Engen N; Ensrud K; Hoy JF;
HIV Med; 2020 Jan; 21(1):64-70. PubMed ID: 31642586
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort.
Bock P; Fatti G; Grimwood A
Int Health; 2013 Jun; 5(2):132-8. PubMed ID: 24030113
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Swaminathan S; Padmapriyadarsini C; Venkatesan P; Narendran G; Ramesh Kumar S; Iliayas S; Menon PA; Selvaraju S; Pooranagangadevi NP; Bhavani PK; Ponnuraja C; Dilip M; Ramachandran R
Clin Infect Dis; 2011 Oct; 53(7):716-24. PubMed ID: 21890776
[TBL] [Abstract][Full Text] [Related]
17. No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.
Nkhoma ET; Coumbis J; Farr AM; Johnston SS; Chu BC; Rosenblatt LC; Seekins D; Villasis-Keever A
Medicine (Baltimore); 2016 Jan; 95(3):e2480. PubMed ID: 26817882
[TBL] [Abstract][Full Text] [Related]
18. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Baker JV; Sharma S; Achhra AC; Bernardino JI; Bogner JR; Duprez D; Emery S; Gazzard B; Gordin J; Grandits G; Phillips AN; Schwarze S; Soliman EZ; Spector SA; Tambussi G; Lundgren J;
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28533305
[TBL] [Abstract][Full Text] [Related]
19. Durability of first-line antiretroviral regimens in the era of integrase inhibitors: a cohort of HIV-positive individuals in Spain, 2014-2015.
Jarrin I; Suarez-Garcia I; Moreno C; Tasias M; Del Romero J; Palacios R; Peraire J; Gorgolas M; Moreno S;
Antivir Ther; 2019; 24(3):167-175. PubMed ID: 30747107
[TBL] [Abstract][Full Text] [Related]
20. Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Dejesus E; Young B; Morales-Ramirez JO; Sloan L; Ward DJ; Flaherty JF; Ebrahimi R; Maa JF; Reilly K; Ecker J; McColl D; Seekins D; Farajallah A;
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):163-74. PubMed ID: 19357529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
